HEMOXMOD (U.S. Trademark Serial Number 87721045) is a United States trademark of Global Blood Therapeutics, Inc.. The goods and services include: Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions . The correspondent is Harold Milstein of SHEPPARD MULLIN RICHTER & HAMPTON LLP.
This trademark was filed on December 14, 2017 as United States Trademark Application Serial Number 87721045. This trademark application is still pending and does not yet have a registration number.
Trademark PTO Status History
August 02, 2021 – ABANDONMENT NOTICE E-MAILED – NO USE STATEMENT FILED
August 02, 2021 – ABANDONMENT – NO USE STATEMENT FILED
January 07, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
January 06, 2021 – SOU EXTENSION 5 GRANTED
December 15, 2020 – SOU EXTENSION 5 FILED
January 04, 2021 – CASE ASSIGNED TO INTENT TO USE PARALEGAL
December 15, 2020 – TEAS EXTENSION RECEIVED
September 01, 2020 – APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
View full trademark status information at USPTO
Ownership History
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc.
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.